Back to top

Theriva Biologics Presents Promising VCN-01 Study Results

Theriva Biologics ( ($TOVX) ) has shared an announcement. Theriva Biologics announced the results of a Phase 1 study on VCN-01, an oncolytic adenov...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Theriva Biologics, Inc. (TOVX)